| Literature DB >> 22743093 |
S Boutayeb1, Y Bensouda, Z Fadoulkhair, K Bakkraoui, M Bachouchi, H Errihani.
Abstract
Targeted therapies have an increasing importance in digestive oncology. These new treatments have been authorized in colon cancer, gastric cancer, pancreatic cancer, endocrine cancer and gastrointestinal stromal tumors. The oncologist should develop high abilities to use these therapies especially concerning the indications, response's biomarkers, toxicities and evaluation methods.Entities:
Mesh：
Substances：
Year: 2012 PMID： 22743093 DOI： 10.1016/j.patbio.2012.05.013
Source DB: PubMed Journal: Pathol Biol (Paris) ISSN： 0369-8114